ArticleCell & bioscience2020

Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cells.

Qing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.